Welcome to our dedicated page for Kadant SEC filings (Ticker: KAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kadant Inc. (NYSE: KAI) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Kadant is incorporated in Delaware and lists its common stock on the New York Stock Exchange under the symbol KAI, as noted in its Form 8-K filings. Through these documents, investors can review how the company reports its financial results, describes material events, and manages its capital structure.
Regular current reports on Form 8-K furnish Kadant’s quarterly earnings press releases and investor presentation materials. In these filings, the company discusses revenue, net income, earnings per share, bookings, and cash flow, and presents non-GAAP measures such as organic revenue, adjusted net income, adjusted EPS, EBITDA, adjusted EBITDA, adjusted EBITDA margin, and free cash flow. The filings explain which items are excluded from these non-GAAP metrics and why management uses them to assess underlying performance.
Other 8-K filings document material corporate actions, such as the completion of the acquisition of Clyde Industries Holdings, Inc. and amendments to Kadant’s Amended and Restated Credit Agreement. For example, one filing describes an Eighth Amendment that increased revolving loan commitments, extended the maturity of the unsecured credit facility, adjusted multicurrency and letter of credit sublimits, and added an Australian subsidiary as an authorized borrower. These disclosures help readers understand Kadant’s financing arrangements and acquisition activity.
On Stock Titan, Kadant’s filings are updated as they are made available through the EDGAR system. AI-powered summaries highlight the key points in lengthy documents, helping users quickly identify items related to earnings, credit facilities, acquisitions, and other significant developments. Investors can also use this page to trace the history of Kadant’s reported non-GAAP measures, review the terms of its credit agreements, and follow the regulatory record surrounding its strategic transactions.
Kadant Inc. acquired all outstanding equity securities of Clyde Industries, completing a purchase governed by an Acquisition Agreement that includes customary representations, warranties and restrictive covenants.
Kadant obtained a representation and warranty insurance policy to provide recourse for breaches, and a portion of the cash consideration is being held to cover customary post-closing adjustments. The company said the Acquisition Agreement will be filed as an exhibit to its Quarterly Report for the fiscal quarter ended September 27, 2025.
A press release is furnished as Exhibit 99.1 and Kadant will hold a webcast and conference call on October 9, 2025 at 11:00 a.m. Eastern Time; an investor presentation will be filed with the SEC and posted on kadant.com.
Kadant Inc. amended its unsecured credit facility through an Eighth Amendment that materially improves borrowing capacity and flexibility. The amendment raises the revolving loan commitments from $400 million to $750 million, extends maturity to September 26, 2030 (five years from the amendment), and enlarges several sublimits: the multicurrency sublimit from $300 million to $400 million, the letter of credit sublimit from $80 million to $100 million, and the swingline loan sublimit from $10 million to $15 million. It also removes the lowest tier of the pricing grid, eliminates certain credit spread adjustments for SOFR, SONIA and CORRA borrowings, and adds Australian Dollars and the company’s Australian subsidiary Vayeron Pty Ltd as an authorized borrower. The filing states the amendment is filed as Exhibit 10.1 and incorporated by reference.
John M. Albertine, a director of Kadant Inc. (KAI), reported the partial vesting and delivery of 132 shares arising from restricted stock units on 09/27/2025. The transaction reflects the vesting terms of an RSU award dated May 14, 2025, with the remaining shares scheduled to vest on the last day of the issuer's fiscal 2025 fourth quarter only if the recipient continues to serve as a director. Following this transaction the reporting person directly beneficially owns 7,703 shares of Kadant common stock.
Leonard Thomas C, a director of Kadant Inc. (KAI), received shares from a partial vesting of a restricted stock unit award on 09/27/2025. The Form 4 reports 132 shares acquired pursuant to the RSU award agreement dated May 14, 2025, with delivery of shares governed by that award. The filing shows 4,382 shares of Common Stock beneficially owned following the non-derivative transaction and lists 131 shares as beneficially owned following the derivative/underlying reporting line. The remainder of the RSU award vests on the last day of the issuer's fourth quarter of fiscal 2025 provided the recipient continues to serve as a director. The form was signed by power of attorney on 09/29/2025.
Kadant Inc. director Rebecca Martinez O'Mara reported a partial vesting and delivery of 132 shares of common stock on September 27, 2025 pursuant to a restricted stock unit award agreement dated May 14, 2025. After the transaction the reporting person beneficially owns 1,840 shares. The filing states the remainder of the award will vest on the last day of the issuer's fiscal 2025 fourth quarter if the recipient continues to serve as a director.
Jonathan W. Painter, a director of Kadant Inc. (KAI), experienced a partial vesting of a restricted stock unit award on 09/27/2025. Under the RSU agreement dated 05/14/2025, 132 shares were delivered to Painter on that date at a $0 price as part of the award terms; the remaining shares will vest on the last day of the issuer's fiscal 2025 fourth quarter if he continues to serve as a director. Following the reported transaction, Painter beneficially owns 8,617 shares.
KADANT INC (KAI) director Russell Erin L reported a transaction on 09/27/2025 involving restricted stock units and common stock. The filing shows partial vesting and delivery of 132 shares pursuant to a restricted stock unit award agreement dated 05/14/2025, resulting in 4,501 shares beneficially owned following the transaction. The remaining RSU shares vest on the last day of the issuer's fiscal 2025 fourth quarter only if the director continues to serve. The Form 4 was signed by power of attorney on 09/29/2025.
Insider transaction: Kadant Inc. director Leonard Thomas C reported a sale of 415 shares of Kadant common stock on 08/27/2025 at a reported price of $338.4138 per share. After the transaction he beneficially owned 4,250 shares directly. The Form 4 was signed under power of attorney.
Kadant Inc. (KAI) Form 144 notice reports a proposed sale of 415 shares of common stock through Wells Fargo Clearing Services on the NYSE, with an aggregate market value of $140,309.73 and an approximate sale date of 08/27/2025. The shares were acquired as restricted stock units: 151 shares vested on 12/28/2024 and 264 shares vested on 06/01/2025. The filer states no securities of the issuer were sold by the person in the past three months and affirms they are not aware of any undisclosed material adverse information about the issuer. The notice identifies Wells Fargo as the broker and lists the signature and criminal-warning language required by the form.
Insider sale by Kadant Inc. officer — The filing shows Thomas Andrew Blanchard, identified as a Vice President and reporting person for Kadant Inc. (KAI), sold 714 shares of the issuer's common stock on 08/18/2025 under transaction code S. The sale price is reported as $343 per share and, after the transaction, Blanchard beneficially owned 1,188 shares, held directly. The Form 4 was signed by Stacy D. Krause by power of attorney on 08/19/2025.